FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,184 resources

Source: Text:

By Version

By Authority

  • none: 1,983
  • hl7: 12,201

 

Start Prev Rows 2600 - 2800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2532.jsonCongenital Cytomegalovirus (Tests for CMV Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2533.jsonCongenital Cytomegalovirus (Tests for CMV Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.268.jsonMumps (Tests for mumps virus IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.272.jsonPresent or Positive Lab Result Valueactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.282.jsonVaricella (Tests for Varicella zoster virus by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.283.jsonVaricella (Tests for Varicella zoster virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.285.jsonEncephalitis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.287.jsonVaricella (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.289.jsonCarbon Monoxide Poisoning (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.293.jsonToxic Effects of Lead (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.297.jsonMeasles (Tests for measles virus Nucleic Acid)active2025-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.299.jsonMeasles (Tests for measles virus IgM Antibody)active2025-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.300.jsonMeningococcal Disease (Organism or Substance in Lab Results)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.301.jsonShigellosis (Tests for Shigella species by Culture and Identification Method)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.307.jsonLeptospirosis (Tests for Leptospira IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.308.jsonInvasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.310.jsonBacteria (Tests by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.311.jsonViruses (Tests by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.316.jsonRubella (Tests for rubella virus IgM Antibody)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.317.jsonShigellosis (Tests for Shigella species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.319.jsonFungi (Tests by Culture and Identification Method)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.322.jsonPesticide Related Illness (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.329.jsonApnea (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.330.jsonApnea (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.333.jsonShigellosis (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.335.jsonInfluenza (Tests for influenza A virus by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.336.jsonInfluenza (Tests for influenza A or B virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.340.jsonInfluenza (influenza A or B virus in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.341.jsonCampylobacteriosis (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.342.jsonCampylobacteriosis (Tests for Campylobacter species by Culture and Identification Method)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.343.jsonCampylobacteriosis (Tests for Campylobacter species Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.344.jsonCampylobacteriosis (Tests for Campylobacter species Antigen)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.349.jsonHepatitis A (Tests for hepatitis A virus IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.353.jsonDiarrhea (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.356.jsonHIV Infection (Organism or Substance in Lab Results)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.359.jsonBotulism (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.362.jsonHansen’s Disease (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.365.jsonSilicosis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.366.jsonSilicosis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.371.jsonCryptosporidiosis (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.372.jsonCryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.375.jsonCyclosporiasis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.376.jsonCyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.379.jsonGiardiasis (Tests for Giardia species Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.384.jsonListeriosis (Tests for Listeria monocytogenes Nucleic Acid)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.386.jsonVibriosis (Organism or Substance in Lab Results)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.388.jsonVibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.390.jsonTrichinellosis (Tests for Trichinella species Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.395.jsonSyphilis (Disorders) (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.396.jsonSyphilis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.398.jsonHepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.399.jsonHepatitis C Virus Infection (Tests for hepatitis C virus Antigen)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.40.jsonSTEC Infection (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.400.jsonHepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.401.jsonHepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.403.jsonHepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.405.jsonHantavirus Infection and Diseases (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.407.jsonHepatitis C Virus Infection (Tests for hepatitis C virus Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.408.jsonHepatitis B Virus Infection (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.422.jsonTuberculosis (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.427.jsonSTEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.43.jsonGonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.436.jsonCoccidioidomycosis (Tests for Coccidioides species IgM Antibody)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.437.jsonCoccidioidomycosis (Tests for Coccidioides species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.438.jsonCoccidioidomycosis (Tests for Coccidioides species Antigen)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.44.jsonGonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.445.jsonLegionellosis (Tests for Legionella species Antigen)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.446.jsonLegionellosis (Tests for Legionella species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.451.jsonTuberculosis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.460.jsonHIV Infection or AIDS (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.464.jsonMalaria (Tests for Plasmodium species Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.468.jsonLeptospirosis (Tests for Leptospira Nucleic Acid)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.471.jsonLeptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.472.jsonLeptospirosis (Tests for Leptospira Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.476.jsonBabesia species (Tests by Microscopic Observation in Blood)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.478.jsonAnthrax (Tests for Bacillus anthracis by Culture and Identification Method)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.479.jsonAnthrax (Tests for Bacillus anthracis Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.48.jsonSalmonellosis (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.480.jsonAnthrax (Tests for Bacillus anthracis Antigen)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.481.jsonAnthrax (Tests for Bacillus anthracis Antibody)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.494.jsonEhrlichiosis (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.496.jsonQ Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen])active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.500.jsonQ Fever (Tests for Coxiella burnetii Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.505.jsonToxic Shock Syndrome (TSS) (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.507.jsonToxic Shock Syndrome (TSS) (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.512.jsonBrucellosis (Tests for Brucella species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.515.jsonBrucellosis (Tests for Brucella species Antibody [Quantitative])active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.516.jsonBrucellosis (Organism or Substance in Lab Results)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.519.jsonDengue Virus Infection (Tests for dengue virus Nucleic Acid)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.523.jsonDengue Virus Infection (Tests for dengue virus Antigen)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.524.jsonDengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative])active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.525.jsonDengue Virus Infection (Tests for dengue virus IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.527.jsonDengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative])active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.530.jsonBorrelia species (Tests for Nucleic Acid)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.531.jsonLyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.532.jsonLyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.534.jsonSmallpox (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.548.jsonSt. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative])active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.550.jsonSyphilis (Tests for Treponema pallidum Nucleic Acid)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.553.jsonAnaplasma species (Tests by Microscopic Observation)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.555.jsonYellow Fever (Tests for yellow fever virus Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.557.jsonYellow Fever (Tests for yellow fever virus Antibody [Quantitative])active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.56.jsonDiarrhea (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.560.jsonWest Nile Virus Infection (Tests for West Nile virus Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.569.jsonPlague (Tests for Yersinia pestis Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.58.jsonPertussis (Tests for Bordetella pertussis Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.595.jsonTularemia (Tests for Francisella tularensis Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.598.jsonTularemia (Tests for Francisella tularensis Antibody)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.6.jsonDiphtheria (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.605.jsonOrganisms (Tests by Microscopic Observation by Acid Fast Stain)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.606.jsonTuberculosis (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.614.jsonPertussis (Tests for Bordetella pertussis Toxin Antibody)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.621.jsonInspiratory Whoop (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.632.jsonChlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.645.jsonPertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.648.jsonVomiting (ICD10CM)active2023-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.650.jsonJaundice (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.652.jsonBacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.660.jsonHypertonia [Excluding Congenital Hypertonia] (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.662.jsonChest Pain (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.663.jsonErythema Nodosum (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.664.jsonCongenital Zika Syndromes (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.665.jsonCongenital Zika Syndromes (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.666.jsonGuillain Barré syndrome (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.668.jsonRash (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.671.jsonFever (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.672.jsonArthralgia (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.673.jsonArthralgia (ICD10CM)active2023-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.674.jsonConjunctivitis (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.675.jsonConjunctivitis (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.676.jsonPregnant (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.677.jsonPostpartum (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.678.jsonPostpartum (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.679.jsonHearing Loss (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.680.jsonAbdominal Pain (ICD10CM)active2023-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.681.jsonAbdominal Pain (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.686.jsonErythema Multiforme (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.687.jsonMyalgia (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.689.jsonPeriorbital Edema (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.691.jsonEosinophilia (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.692.jsonEosinophilia (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.70.jsonSalmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.702.jsonWeight Loss (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.705.jsonSyphilis (Tests for Treponemal or Non Treponemal Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.709.jsonCough [Non Productive] (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.71.jsonSalmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.711.jsonWound Infection (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.712.jsonPneumonia (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.713.jsonSepsis [Septicemia] [Unspecified Organism] (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.714.jsonSepsis [Septicemia] [Unspecified Organism] (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.715.jsonMeningitis (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.717.jsonCellulitis (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.718.jsonCellulitis (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.719.jsonMyositis [Unspecified Cause] (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.720.jsonMyositis [Unspecified Cause] (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.721.jsonOtitis Media (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.722.jsonOtitis Media (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.723.jsonOtitis Externa (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.724.jsonOtitis Externa (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.727.jsonAcute Upper Respiratory Illness (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.728.jsonHIV Infection (Tests for HIV Nucleic Acid [Qualitative])active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.730.jsonHIV Infection (Tests for HIV Antibody)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.733.jsonPerinatal Hepatitis B Virus Infection (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.744.jsonCoccidioidomycosis (Tests for Coccidioides species IgG Antibody)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.746.jsonTreponema pallidum (Tests by Microscopic Observation)active2022-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.750.jsonChest Pain (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.755.jsonAcute Upper Respiratory Illness (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.756.jsonPurpura (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.757.jsonMuscle Spasms (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.758.jsonMuscle Spasms (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.762.jsonMumps (Test Panels for mumps virus IgM IgG Antibody)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.763.jsonParotitis [Unspecified Cause] (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.764.jsonMumps (Tests for mumps virus IgG Antibody)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.765.jsonAseptic Meningitis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.766.jsonEncephalitis (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.767.jsonHearing Loss (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.770.jsonInvasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.773.jsonInvasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.777.jsonMastitis (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.779.jsonPancreatitis (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.780.jsonPancreatitis (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.782.jsonRubella (Test Panels for rubella virus IgM IgG Antibody)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.785.jsonOpioid Overdose and Poisoning (Tests for Opioids [Qualitative])active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.789.jsonPurpura (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.79.jsonCampylobacteriosis (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.792.jsonNovel Influenza A Virus Infection (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.793.jsonNovel Influenza A Virus Infection (Disorders) (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.794.jsonSore Throat (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.795.jsonInfluenza (influenza A virus in Lab Results)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.796.jsonInfluenza (Novel influenza A virus in Lab Results)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.797.jsonInfluenza (Tests for influenza A or B virus by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.798.jsonInfluenza (Tests for influenza A virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.799.jsonInfluenza (Tests for influenza A virus Antigen)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.802.jsonInfluenza (Tests for Novel influenza A virus Nucleic Acid)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.803.jsonTests by Microscopic Observation in Tissue by H&E or PAS Stainactive2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.808.jsonHeadache (ICD10CM)active2023-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.809.jsonHeadache (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.810.jsonBackache (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.811.jsonBackache (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.815.jsonNU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative])active2023-06hl7loinc